Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 1.11% | 62.18 | 0.0% | $1999.69m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.18% | 599.47 | 2.5% | $1212.04m | |
| GILD | Gilead Sciences, Inc. | -3.43% | 75.16 | 1.0% | $972.03m | |
| NVAX | Novavax, Inc. | 14.73% | 52.82 | 102.0% | $711.68m | |
| AMGN | Amgen, Inc. | -1.22% | 226.91 | 1.3% | $619.06m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.46% | 286.64 | 1.9% | $592.02m | |
| BIIB | Biogen, Inc. | -1.84% | 301.45 | 1.6% | $385.60m | |
| ILMN | Illumina, Inc. | 0.65% | 365.41 | 3.5% | $384.25m | |
| SRNE | Sorrento Therapeutics, Inc. | -0.99% | 5.00 | 1.8% | $320.03m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.82% | 118.92 | 2.0% | $296.17m | |
| SGEN | Seattle Genetics, Inc. | 1.15% | 159.02 | 6.1% | $258.80m | |
| A | Agilent Technologies, Inc. | 2.01% | 89.91 | 1.6% | $212.68m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.79% | 107.39 | 4.3% | $185.56m | |
| MGNX | MacroGenics, Inc. | 9.67% | 21.10 | 6.2% | $174.18m | |
| INCY | Incyte Corp. | -0.16% | 101.75 | 2.5% | $166.58m |
Company Profile
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.